Version: 1.0.0 | Published: 8 Oct 2024 | Updated: 229 days ago
Summary
DOI Name:
10.48329/4jwp-4951
Documentation
Associated Media:
Description:
CPRD GOLD linked Systemic Anti-Cancer Treatment (SACT) data covers chemotherapy treatment for all solid tumour and haematological malignancies, including those in clinical trials. Information is included about programme and regime of treatment, and the outcome for each treatment.
Coverage
Spatial:
United Kingdom,England
Typical Age Range:
0-115
Follow Up:
1 - 10 Years
Pathway:
Cancer registration data are collected from a range of health care provider
systems and other services.
Provenance
Origin
Sources:
EPR
Collection Situations:
- Clinic
- Community
- Secondary care - In-patients
- Secondary care - Outpatients
Temporal
Accrual Periodicity:
Quarterly
Distribution Release Date:
06 September 2021
Start Date:
01 January 2014
End Date:
31 December 2018
Time Lag:
More than 6 months
Accessibility
Access
Access Rights:
Access Service:
Access to CPRD data, including UK Primary Care Data, and linked data such as
Hospital Episode Statistics, is subject to protocol approval via CPRD’s Research
Data Governance (RDG) Process. Independent scientific and patient advice is
provided by Expert Review Committees (ERCs) and the Central Advisory Committee
(CAC): https://www.cprd.com/research-applications
Access Request Cost:
Delivery Lead Time:
Not applicable
Jurisdictions:
GB-ENG
Data Controller:
Clinical Practice Research Datalink (CPRD)
Data Processor:
CPRD
Usage
Data Use Limitations:
- General research use
- No linkage
- Research-specific restrictions
- Research use only
Data Use Requirements:
- Geographical restrictions
- Institution-specific restrictions
- Project-specific restrictions
- Time limit on use
- User-specific restriction
Resource Creators:
Public Health England (PHE) via the National Cancer Registration and Analysis Service (NCRAS)
Format and Standards
Vocabulary Encoding Schemes:
- ICD10
- ICDO3
- OPCS4
Languages:
en
Formats:
Tab delimited text
Observations
Statistical Population
Population Description
Population Size
Measured Property
Observation Date
Persons
Number of CPRD GOLD patients matched to a single cancer identifier
901965
Count
06 September 2021